We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$4.73B
AUM Growth
+$232M
Cap. Flow
-$76M
Cap. Flow %
-1.6%
Top 10 Hldgs %
17.46%
Holding
1,668
New
59
Increased
597
Reduced
846
Closed
63

Sector Composition

Rank Sector Weight
1 Technology 15.75%
2 Financials 14.08%
3 Healthcare 12.26%
4 Industrials 8.83%
5 Consumer Discretionary 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNV icon
1151
Franco-Nevada
FNV
$46B
$121K ﹤0.01%
1,168
GTES icon
1152
Gates Industrial Corporation Ltd.
GTES
$7.15B
$120K ﹤0.01%
8,733
+248
+3% +$2.82K
SLP icon
1153
Simulations Plus
SLP
$371M
$119K ﹤0.01%
4,097
-3
-0.1% -$102
BLMN icon
1154
Bloomin' Brands
BLMN
$938M
$117K ﹤0.01%
+5,308
New +$113K
SEI
1155
Solaris Energy Infrastructure
SEI
$3.82B
$117K ﹤0.01%
8,350
+460
+6% +$5.53K
BALL icon
1156
Ball Corp
BALL
$16.8B
$114K ﹤0.01%
1,770
-1,012
-36% -$68.6K
XLU icon
1157
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
$114K ﹤0.01%
3,540
-8,006
-69% -$254K
HTZ
1158
DELISTED
Hertz Global Holdings, Inc.
HTZ
$114K ﹤0.01%
7,249
+420
+6% +$6.29K
TGE
1159
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$114K ﹤0.01%
5,132
-4,214
-45% -$80.8K
A icon
1160
Agilent Technologies
A
$41.2B
$113K ﹤0.01%
1,338
GH icon
1161
Guardant Health
GH
$22.6B
$113K ﹤0.01%
1,438
+749
+109% +$54K
SAGE
1162
DELISTED
Sage Therapeutics
SAGE
$113K ﹤0.01%
1,568
-2,929
-65% -$360K
TRHC
1163
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$113K ﹤0.01%
2,315
+1,419
+158% +$66.4K
LXFR icon
1164
Luxfer Holdings
LXFR
$458M
$112K ﹤0.01%
6,041
-80
-1% -$1.38K
LIND icon
1165
Lindblad Expeditions
LIND
$2.22B
$111K ﹤0.01%
6,787
+343
+5% +$5.48K
GAP
1166
The Gap Inc
GAP
$7.37B
$111K ﹤0.01%
6,282
-98
-2% -$1.67K
VREX icon
1167
Varex Imaging
VREX
$523M
$110K ﹤0.01%
3,704
+432
+13% +$12.9K
WLDN icon
1168
Willdan Group
WLDN
$1.3B
$110K ﹤0.01%
3,460
-182
-5% -$5.77K
RCM
1169
DELISTED
R1 RCM Inc. Common Stock
RCM
$109K ﹤0.01%
8,424
-1,792
-18% -$20.5K
ELF icon
1170
e.l.f. Beauty
ELF
$5.81B
$108K ﹤0.01%
6,677
-1,332
-17% -$22.2K
POST icon
1171
Post Holdings
POST
$3.57B
$108K ﹤0.01%
+1,511
New +$103K
STC icon
1172
Stewart Information Services
STC
$2.08B
$107K ﹤0.01%
2,623
+309
+13% +$12.7K
USFD icon
1173
US Foods
USFD
$24B
$107K ﹤0.01%
2,543
AMCX icon
1174
AMC Global Media
AMCX
$489M
$105K ﹤0.01%
2,659
-123
-4% -$5.17K
FTV icon
1175
Fortive
FTV
$18.6B
$105K ﹤0.01%
2,158
-5
-0.2% -$226

Similar funds

Oppenheimer Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Oppenheimer Asset Management held 1,668 positions worth $4.73B, up 5.2% from $4.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer Asset Management's Q4 2019 filing shows 59 new, 597 increased, 846 reduced and 63 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 178,478 shares worth $9.59M. The largest sale was SunTrust Banks, Inc., an estimated $19.1M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer Asset Management's largest Q4 2019 buy was Vanguard FTSE All-World ex-US ETF: 178,478 shares worth $9.59M.
  • Oppenheimer Asset Management added most to Vanguard Morningstar Total Stock Market ETF in Q4 2019, an estimated $9.54M increase.
  • Oppenheimer Asset Management's biggest Q4 2019 reduction was SPX Corp, cutting an estimated $12.1M.
  • Oppenheimer Asset Management fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $19.1M.
  • Oppenheimer Asset Management's ten largest holdings make up 17% of its $4.73B portfolio in Q4 2019.
  • Oppenheimer Asset Management opened 59 new positions and closed 63 in Q4 2019.
  • Oppenheimer Asset Management's portfolio value rose 5.2% quarter-over-quarter to $4.73B.

Based on Oppenheimer Asset Management's 13F filing for Q4 2019, filed 7 Feb 2020.